123 related articles for article (PubMed ID: 26951551)
1. Catalog of genetic progression of human cancers: breast cancer.
Desmedt C; Yates L; Kulka J
Cancer Metastasis Rev; 2016 Mar; 35(1):49-62. PubMed ID: 26951551
[TBL] [Abstract][Full Text] [Related]
2. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
Savas P; Teo ZL; Lefevre C; Flensburg C; Caramia F; Alsop K; Mansour M; Francis PA; Thorne HA; Silva MJ; Kanu N; Dietzen M; Rowan A; Kschischo M; Fox S; Bowtell DD; Dawson SJ; Speed TP; Swanton C; Loi S
PLoS Med; 2016 Dec; 13(12):e1002204. PubMed ID: 28027312
[TBL] [Abstract][Full Text] [Related]
3. Subclonal diversification of primary breast cancer revealed by multiregion sequencing.
Yates LR; Gerstung M; Knappskog S; Desmedt C; Gundem G; Van Loo P; Aas T; Alexandrov LB; Larsimont D; Davies H; Li Y; Ju YS; Ramakrishna M; Haugland HK; Lilleng PK; Nik-Zainal S; McLaren S; Butler A; Martin S; Glodzik D; Menzies A; Raine K; Hinton J; Jones D; Mudie LJ; Jiang B; Vincent D; Greene-Colozzi A; Adnet PY; Fatima A; Maetens M; Ignatiadis M; Stratton MR; Sotiriou C; Richardson AL; Lønning PE; Wedge DC; Campbell PJ
Nat Med; 2015 Jul; 21(7):751-9. PubMed ID: 26099045
[TBL] [Abstract][Full Text] [Related]
4. Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.
Maxwell KN; Soucier-Ernst D; Tahirovic E; Troxel AB; Clark C; Feldman M; Colameco C; Kakrecha B; Langer M; Lieberman D; Morrissette JJD; Paul MR; Pan TC; Yee S; Shih N; Carpenter E; Chodosh LA; DeMichele A
Breast Cancer Res Treat; 2017 Aug; 164(3):627-638. PubMed ID: 28500398
[TBL] [Abstract][Full Text] [Related]
5. Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis.
Krøigård AB; Larsen MJ; Lænkholm AV; Knoop AS; Jensen JD; Bak M; Mollenhauer J; Kruse TA; Thomassen M
Oncotarget; 2015 Mar; 6(8):5634-49. PubMed ID: 25730902
[TBL] [Abstract][Full Text] [Related]
6. Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer.
Yates LR; Desmedt C
Clin Cancer Res; 2017 Jun; 23(11):2630-2639. PubMed ID: 28572257
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral heterogeneity and subclonal diversification of early breast cancer.
Yates LR
Breast; 2017 Aug; 34 Suppl 1():S36-S42. PubMed ID: 28666921
[TBL] [Abstract][Full Text] [Related]
8. High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts.
Kim H; Kumar P; Menghi F; Noorbakhsh J; Cerveira E; Ryan M; Zhu Q; Ananda G; George J; Chen HC; Mockus S; Zhang C; Yang Y; Keck J; Karuturi RKM; Bult CJ; Lee C; Liu ET; Chuang JH
Sci Rep; 2018 Dec; 8(1):17937. PubMed ID: 30560892
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
Ross JS; Badve S; Wang K; Sheehan CE; Boguniewicz AB; Otto GA; Yelensky R; Lipson D; Ali S; Morosini D; Chliemlecki J; Elvin JA; Miller VA; Stephens PJ
Arch Pathol Lab Med; 2015 May; 139(5):642-9. PubMed ID: 25927147
[TBL] [Abstract][Full Text] [Related]
10. Genomic tumor evolution of breast cancer.
Sato F; Saji S; Toi M
Breast Cancer; 2016 Jan; 23(1):4-11. PubMed ID: 25998191
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.
Ng CK; Schultheis AM; Bidard FC; Weigelt B; Reis-Filho JS
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713166
[TBL] [Abstract][Full Text] [Related]
12. Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.
Lawrence-Paul MR; Pan TC; Pant DK; Shih NNC; Chen Y; Belka GK; Feldman M; DeMichele A; Chodosh LA
Genome Med; 2024 Feb; 16(1):26. PubMed ID: 38321573
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
McBryan J; Fagan A; McCartan D; Bane FT; Varešlija D; Cocchiglia S; Byrne C; Bolger J; McIlroy M; Hudson L; Tibbitts P; Gaora PÓ; Hill AD; Young LS
Clin Cancer Res; 2015 Dec; 21(23):5371-9. PubMed ID: 26240272
[TBL] [Abstract][Full Text] [Related]
14. Uncovering the genomic heterogeneity of multifocal breast cancer.
Desmedt C; Fumagalli D; Pietri E; Zoppoli G; Brown D; Nik-Zainal S; Gundem G; Rothé F; Majjaj S; Garuti A; Carminati E; Loi S; Van Brussel T; Boeckx B; Maetens M; Mudie L; Vincent D; Kheddoumi N; Serra L; Massa I; Ballestrero A; Amadori D; Salgado R; de Wind A; Lambrechts D; Piccart M; Larsimont D; Campbell PJ; Sotiriou C
J Pathol; 2015 Aug; 236(4):457-66. PubMed ID: 25850943
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic aspects of breast cancer progression and therapy.
Byler S; Goldgar S; Heerboth S; Leary M; Housman G; Moulton K; Sarkar S
Anticancer Res; 2014 Mar; 34(3):1071-7. PubMed ID: 24596345
[TBL] [Abstract][Full Text] [Related]
16. Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
Tang MH; Dahlgren M; Brueffer C; Tjitrowirjo T; Winter C; Chen Y; Olsson E; Wang K; Törngren T; Sjöström M; Grabau D; Bendahl PO; Rydén L; Niméus E; Saal LH; Borg Å; Gruvberger-Saal SK
Oncotarget; 2015 Nov; 6(35):37169-84. PubMed ID: 26439695
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
[TBL] [Abstract][Full Text] [Related]
19. Identification of genomic signatures in circulating tumor cells from breast cancer.
Kanwar N; Hu P; Bedard P; Clemons M; McCready D; Done SJ
Int J Cancer; 2015 Jul; 137(2):332-44. PubMed ID: 25529931
[TBL] [Abstract][Full Text] [Related]
20. What to expect from high throughput genomics in metastatic breast cancers?
Onesti CE; Vicier C; André F
Breast; 2015 Nov; 24 Suppl 2():S19-22. PubMed ID: 26238439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
